Biolab

Founded in 1997, Biolab Farmacêutica is a leading force in Brazilian healthcare, renowned for its commitment to quality and scientific excellence with a portfolio of over 425 products spanning key therapeutic areas such as cardiology, dermatology, pediatrics, women’s health, and veterinary care. Biolab delivers innovative and accessible solutions that elevate patient and animal health.

The company’s infrastructure includes three manufacturing facilities and Research, Development & Innovation (RDI) centers in Brazil and Canada, which enable the development of advanced treatments for diverse health needs.

Founded in 1997, Biolab Farmacêutica is a leader in Brazilian healthcare, recognized for its dedication to quality and scientific excellence. With a portfolio of over 425 products spanning key therapeutic areas, including cardiology, dermatology, pediatrics, women’s health, and veterinary care, Biolab is committed to delivering innovative and accessible solutions that improve patient outcomes. The company’s robust infrastructure features three manufacturing facilities and Research, Development, & Innovation (RDI) centers in Brazil and Canada, reinforcing its ability to develop advanced treatments that address diverse health needs.

Biolab’s mission to enhance well-being is supported by its expanding international presence and collaborative approach to healthcare. With a team of over 4,000 professionals and one of the largest sales forces in Brazil, Biolab fosters strong relationships with healthcare providers, conducting more than 320,000 visits annually. This extensive network underscores Biolab’s experience and solidifies its position as a trusted partner in healthcare, advancing solutions to meet patients’ evolving needs.

As part of the Biolab Group, Exzell Pharma benefits from the expertise, resources, and strategic vision of this dynamic organization. This collaboration enables Exzell, a proudly Canadian company, to expand its healthcare offerings across Canada, focusing on both human and animal health. With Biolab’s trust in the Canadian market and its support, Exzell is well-positioned to forge new partnerships and develop innovative products that improve quality of life and promote better health outcomes across borders.